Ephrin A2 抗体 (cleaved)
Quick Overview for Ephrin A2 抗体 (cleaved) (ABIN2878342)
抗原
See all Ephrin A2 (EFNA2) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- cleaved
- 
                                            特异性
- Human EFNA2 / Ephrin A2 Cleaved
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide from Human Ephrin-A2.
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: WB (1:500 - 1:1000)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, 0.1 % sodium azide, 50 % glycerol.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            注意事项
- Avoid freeze-thaw cycles.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
 
- 
                                            
- 
    - Ephrin A2 (EFNA2)
- 
                                            别名
- EFNA2 / Ephrin A2
- 
                                            背景
- 
                        Name/Gene ID: EFNA2
 Synonyms: EFNA2, EPLG6, HEK7 ligand, Ephrin-A2, LERK-6, LERK6, ELF-1, HEK7-L
- 
                                            基因ID
- 1943
 抗原
- 
                    
 
                                     
                                     
                                    